Advertisement
News
Advertisement

Key blockbuster drugs about to get generic rivals

Sun, 07/24/2011 - 8:17pm
The Associated Press

These are blockbuster drugs, with more than $1 billion in annual global sales, set to go off patent and get generic competition in the U.S. in the next two years:

PATENT ENDS ?BRAND?NAME??????GENERIC?NAME??USE/CONDITIONS?TREATED??MADE/SOLD?BY

Oct. 2011 ?Zyprexa?????????olanzapine????schizophrenia/bipolar???Eli?Lilly

Nov. 2011 ?Lipitor?????????atorvastatin??high?cholesterol????????Pfizer????

March 2012 ?Lexapro?????????escitalopram??depression??????????????Forest?Labs

March 2012 ?Seroquel????????quetiapine????schizophrenia/bipolar???AstraZeneca

March 2012 ?Avapro/Avalide??irbesartan????high?blood?pressure?????Bristol-Myers/Sanofi?

April 2012 ?Provigil????????modafinil?????narcolepsy??????????????Cephalon

May 2012 ?Plavix??????????clopidogrel???clot?prevention?????????Bristol-Myers/Sanofi

July 2012 ?Tricor??????????fenofibrate???high?triglycerides??????Abbott

Aug. 2012 ?Singulair???????montelukast???asthma/allergies????????Merck

Aug. 2012 ?Actos???????????pioglitazone??diabetes????????????????Takeda

Sept. 2012 ?Diovan??????????valsartan?????high?blood?pressure?????Novartis

Sept. 2012 ?Geodon??????????ziprasidone???bipolar?disorder????????Pfizer

Nov. 2012 ?Lidoderm????????lidocaine?????pain?patch??????????????Endo?

Dec. 2012 ?Atacand?????????candesartan???heart?failure???????????AstraZeneca?

March 2013 ?Lovaza??????????omega-3-acid??high?triglycerides??????GlaxoSmithKline???

Aug. 2013 ?Temodar?????????temozolomide??brain?tumors????????????Merck?

___

Note: Patent expiration/generic arrival dates can change due to litigation or regulatory issues.

Sources: Medco Health Solutions Inc., company Web sites.

Advertisement
Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading